Contribution to research on the protective effect of proanthocyanidol-BP1 on adriamycin-induced cardiotoxicity

Acta Veterinaria

Volumn 46, Issue 5-6, 1996, Pages 317-326

  Bogdanović, Gordana ^a   Vuckovic D ^b   Velimirović, Smiljana ^c   Milošević, Mirjana ^d   Baltic V ^a   Kovacevic Z ^d   Pekic B ^c  

^a Institute of Oncology   (Serbia)

^b Institute for Pulmonary Diseases   (Serbia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

^d UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Adriamycin; Cardiotoxicity; Proanthocyanidols; Protection

Indexed keywords

ANIMALIA;

EID: 3042980452     PISSN: 05678315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Allen A. 1992. The cardiotoxicity of chemotherapeutic drugs.Seminars in Oncology 29, 529-542.
2. Bachur, NR., Gordon, SL., Gee, MV., et al. 1977. A general mechanism for microsmal activation of quinone anticancer agents to free radicals Cancer 38, 1745-1752.
3. Barbier, A., Maffrano, J.P., Savi, P., Unković, J., Vilain, P. 1988. Activite angioprotectrice des olygomeres procyandidoliques chez 1′ animal. Congr. Intern. d'Angiologie, Toulouse, 4. oct., 31-40.
4. Bogdanović, G. Velimirović, S., Pekić, B., Miljković, D., Baltić, V. 1995. Effect of flavanol-BP1 on doxorubin-induced cytotoxicity on cell lines. Abstract. 2nd Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries, Ioannina, Greece, Octobar 22-25.
5. Carter, SK. 1975. Adriamycin-A review. J. Natl. Cancer Inst. 55, 1265-1274.
6. Caulfield, J.B., Bittner, V. 1988. Cardiac matrix alterations induced by adriamycin. Am. J. Pathol. 133, 298-305.
7. Danesi, R., Bernardini, N., Marcheti, A., Bernadini, M., Del Tacca, M. 1990. Protective effect of fructose-1, 6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats. Cancer Chemother. Pharma col. 25, 32-332.
8. Dardir, MD., Ferrans, Vj., Mikhael, SY., et al. 1989. Cardiac morphologic and functional changes induced by epirubicin chemotherapy. J. Clin. Oncol. 7, 947-958.
9. Davis, EL. 1991. Long-term complications of antineoplastic agents. J. Pharm. Pract. 4. 131-150.
10. Doroshow, JH. Locker, GH., Myers, CE. 1980. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin J. Clin. Invest. 65, 128-135.
11. Doroshow, J.H., Locker, G.Y., Ifrim, I., Myers, CE 1981. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine, J. Clin. Invest. 68, 1053-1064.
12. Doroshow, J. H. 1983. Effect od anthracycline antibiotics on oxygen radical formation in the rat heart. Cancer. Res. 43, 460-472.
13. Dugen, L. R., 1985. Natural antioxidants. In: Min, DB., Smouse, TH. eds. Flavor chemistry of fat and oil. Am. Oil Chem. Soc. Ohio: Colmus, 261-281.
14. Ferrans, VJ. 1978. Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat. Rep. 62, 955-961.
15. Ferrari, R., Ceconi, D., Curello, S. et al. 1991. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am. J. Med. 91 (suppl 3C), 95-104.
16. Griesser-Aleksić., Nikolić, V., Bogdanović, G., Baltić, V., Spasić, M. 1994. Preventing adriamyxcin's cardiotoxicity by selenium. Onkološki arhiv 2, 195-199.
17. Houlihan, CM., Ho, C-H. 1985. Natural antioxidants. In: Min, DB., Smouse, TH. eds. Flavor Chemistry of fat and oil. Am. Oil. Chem. Soc. Ohio: Colmus 261-281.
18. Kovač, V., Pekić, B. 1991. Proantocijanidoli gvožcrossed d signa i vina. Savremena poljoprivreda 39, 5-17.
19. Laughton, M. J., Evans, P. J., Moroney, M. A., Hoult, IRS., Halliwell, B. 1991. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavanoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ionreducing ability. Biochem. Pharmacol. 42, 1673-1681.
20. Leake, D. 1995. The French paradox. Biochemistry 17, 12-17.
21. Lenzhofer, R., Magometschnigg, D., Dudezak, R., Carni, C., Bolebruch, C., Moser, K. 1983. Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances. Experientia 39, 62-64.
22. Look, M.P., Musch E. 1994. Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 40, 8-15.
23. Masquelier, J. 1987. Vins et radicaux libres. Diététique et Médicine 14, 141-145.
24. McCay, PB 1985. Vitamin E interaction with free radicals and ascorbate. Ann. Rev. Nutr. 5, 323-323.
25. Myers, CE., Liss, RH., Ifrim, J., et al. 1977. The role of lipid peroxidation on cardiac toxicity and tumor response. Science 197, 165-167.
26. Myers, CE., Gianni, L., Zweier, J., et al. 1986. The role of iron in adriamycin biochemistry. Fed. Proc. 45, 2792-2797.
27. Najman, S. 1994. In vitro ispitivanja efekta modulacije funcionalnih karakteristika mišijih i humanih fagocita na mijelopoezu. Disertacija. Novi Sad: Univerzitet u N. Sadu, PMF, Institut za biologiju.
28. Neri, G.C., Bandinelli, M. Neri, B. 1993. Free-radical production and nucleotide loss in anthracycline-induced cardiac damage. Med. Sci. Res. 21, 905-907
29. Pekić, B., Kovać, V. 1993. Postupak za dobijanje proantocijanidola ekstrakcijom iz semenki grožda. YU. Pat. P-205/93.
30. Powell, SR., McCay, PB. 1988. Inhibition of doxorubicin-initiated membrane damage by N-acetyl-cysteine: Possible mediation by thiol-dependent, cytosolic inhibition of lipid-peroxidation. Toxicol. Appl. Pharmacol. 96, 175-184.
31. Saltiel, E., McGuire, W. 1983. Doxorubicin (adriamycin) cardiomyopathy: A critical review. West. J. Med. 139, 332-341.
32. Serafini, M., Ghiselli, A., Ferro-Luzzi, A. 1994. Red wine, tea and antioxidants. Lancet 339, 1523-1526.
33. Sinha, KB. Katki, Ag., Batist, G., Cown, KH. Myers, CE. 1987. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: Implications for the mechanism of action. Biochemistry 26, 377-3781.
34. Spyer, JI., Green, MD., Kramer, E. et. al. 1988. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. N. Engl. J. Med. 106, 814-316.
35. Thomas, CE., Aust. SE. 1986. Release of iron from ferritin by cardiotoxic anthracycline antibiotics. Arch. Biochem. Biophys. 248, 684-695.
36. Uchida, S., Edamatsu, R., Hiramatsu, M., Mori, A., Nonaka, G. J., Nishioka, I., Niwa, M., Ozaki, M. 1987. Condensed tannins scavenge active oxygen free radicals. Med. Sci. Res. 15, 831-832.
37. Van Acker, SABE., Tromp, MNJL., Haenen, GRMM., van der Bijgh, WJF., Bast, A. 1995. Flavonoids as scavengers of nitric oxide radical. Biochem. Biophys. Res. Commun. 214, 755-759.
38. Withehead. TP., Robinson, D., Allaway, S., Syms, J., Hale, A. 1995. Effect of red wine ingestion on the antioxidant capacity of serum. Clin. Chem. 41, 32-35.